Global Dendritic Cell Cancer Vaccine Market Insights and Forecast to 2026

Global Dendritic Cell Cancer Vaccine Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Dendritic Cell Cancer Vaccine Product Introduction
1.2 Market Segments
1.3 Key Dendritic Cell Cancer Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Dendritic Cell Cancer Vaccine Market Size Growth Rate by Type
1.4.2 CreaVax
1.4.3 Sipuleucel-T (Provenge)
1.4.4 Others
1.5 Market by Application
1.5.1 Global Dendritic Cell Cancer Vaccine Market Size Growth Rate by Application
1.5.2 Pediatrics
1.5.3 Adults
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Dendritic Cell Cancer Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Dendritic Cell Cancer Vaccine Revenue 2015-2026
2.1.2 Global Dendritic Cell Cancer Vaccine Sales 2015-2026
2.2 Global Dendritic Cell Cancer Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Dendritic Cell Cancer Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Dendritic Cell Cancer Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Dendritic Cell Cancer Vaccine Competitor Landscape by Players
3.1 Dendritic Cell Cancer Vaccine Sales by Manufacturers
3.1.1 Dendritic Cell Cancer Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Dendritic Cell Cancer Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Dendritic Cell Cancer Vaccine Revenue by Manufacturers
3.2.1 Dendritic Cell Cancer Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Dendritic Cell Cancer Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Dendritic Cell Cancer Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Dendritic Cell Cancer Vaccine Revenue in 2019
3.2.5 Global Dendritic Cell Cancer Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Dendritic Cell Cancer Vaccine Price by Manufacturers
3.4 Dendritic Cell Cancer Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Dendritic Cell Cancer Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Dendritic Cell Cancer Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Dendritic Cell Cancer Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Dendritic Cell Cancer Vaccine Market Size by Type (2015-2020)
4.1.1 Global Dendritic Cell Cancer Vaccine Sales by Type (2015-2020)
4.1.2 Global Dendritic Cell Cancer Vaccine Revenue by Type (2015-2020)
4.1.3 Dendritic Cell Cancer Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Dendritic Cell Cancer Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Dendritic Cell Cancer Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Dendritic Cell Cancer Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Dendritic Cell Cancer Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Dendritic Cell Cancer Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Dendritic Cell Cancer Vaccine Market Size by Application (2015-2020)
5.1.1 Global Dendritic Cell Cancer Vaccine Sales by Application (2015-2020)
5.1.2 Global Dendritic Cell Cancer Vaccine Revenue by Application (2015-2020)
5.1.3 Dendritic Cell Cancer Vaccine Price by Application (2015-2020)
5.2 Dendritic Cell Cancer Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Dendritic Cell Cancer Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Dendritic Cell Cancer Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Dendritic Cell Cancer Vaccine Price Forecast by Application (2021-2026)
6 North America
6.1 North America Dendritic Cell Cancer Vaccine by Country
6.1.1 North America Dendritic Cell Cancer Vaccine Sales by Country
6.1.2 North America Dendritic Cell Cancer Vaccine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Dendritic Cell Cancer Vaccine Market Facts & Figures by Type
6.3 North America Dendritic Cell Cancer Vaccine Market Facts & Figures by Application
7 Europe
7.1 Europe Dendritic Cell Cancer Vaccine by Country
7.1.1 Europe Dendritic Cell Cancer Vaccine Sales by Country
7.1.2 Europe Dendritic Cell Cancer Vaccine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Dendritic Cell Cancer Vaccine Market Facts & Figures by Type
7.3 Europe Dendritic Cell Cancer Vaccine Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Dendritic Cell Cancer Vaccine by Region
8.1.1 Asia Pacific Dendritic Cell Cancer Vaccine Sales by Region
8.1.2 Asia Pacific Dendritic Cell Cancer Vaccine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Dendritic Cell Cancer Vaccine Market Facts & Figures by Type
8.3 Asia Pacific Dendritic Cell Cancer Vaccine Market Facts & Figures by Application
9 Latin America
9.1 Latin America Dendritic Cell Cancer Vaccine by Country
9.1.1 Latin America Dendritic Cell Cancer Vaccine Sales by Country
9.1.2 Latin America Dendritic Cell Cancer Vaccine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Dendritic Cell Cancer Vaccine Market Facts & Figures by Type
9.3 Central & South America Dendritic Cell Cancer Vaccine Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Dendritic Cell Cancer Vaccine by Country
10.1.1 Middle East and Africa Dendritic Cell Cancer Vaccine Sales by Country
10.1.2 Middle East and Africa Dendritic Cell Cancer Vaccine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Dendritic Cell Cancer Vaccine Market Facts & Figures by Type
10.3 Middle East and Africa Dendritic Cell Cancer Vaccine Market Facts & Figures by Application
11 Company Profiles
11.1 Medigene
11.1.1 Medigene Corporation Information
11.1.2 Medigene Description and Business Overview
11.1.3 Medigene Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Medigene Dendritic Cell Cancer Vaccine Products Offered
11.1.5 Medigene Related Developments
11.2 Activarti
11.2.1 Activarti Corporation Information
11.2.2 Activarti Description and Business Overview
11.2.3 Activarti Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Activarti Dendritic Cell Cancer Vaccine Products Offered
11.2.5 Activarti Related Developments
11.3 Argos Therapeutics
11.3.1 Argos Therapeutics Corporation Information
11.3.2 Argos Therapeutics Description and Business Overview
11.3.3 Argos Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Argos Therapeutics Dendritic Cell Cancer Vaccine Products Offered
11.3.5 Argos Therapeutics Related Developments
11.4 Batavia Bioservices
11.4.1 Batavia Bioservices Corporation Information
11.4.2 Batavia Bioservices Description and Business Overview
11.4.3 Batavia Bioservices Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Batavia Bioservices Dendritic Cell Cancer Vaccine Products Offered
11.4.5 Batavia Bioservices Related Developments
11.5 Bellicum Pharmaceuticals
11.5.1 Bellicum Pharmaceuticals Corporation Information
11.5.2 Bellicum Pharmaceuticals Description and Business Overview
11.5.3 Bellicum Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Products Offered
11.5.5 Bellicum Pharmaceuticals Related Developments
11.6 Creagene
11.6.1 Creagene Corporation Information
11.6.2 Creagene Description and Business Overview
11.6.3 Creagene Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Creagene Dendritic Cell Cancer Vaccine Products Offered
11.6.5 Creagene Related Developments
11.7 DanDrit Biotech
11.7.1 DanDrit Biotech Corporation Information
11.7.2 DanDrit Biotech Description and Business Overview
11.7.3 DanDrit Biotech Sales, Revenue and Gross Margin (2015-2020)
11.7.4 DanDrit Biotech Dendritic Cell Cancer Vaccine Products Offered
11.7.5 DanDrit Biotech Related Developments
11.8 DCPrime
11.8.1 DCPrime Corporation Information
11.8.2 DCPrime Description and Business Overview
11.8.3 DCPrime Sales, Revenue and Gross Margin (2015-2020)
11.8.4 DCPrime Dendritic Cell Cancer Vaccine Products Offered
11.8.5 DCPrime Related Developments
11.9 Sanpower (Dendreon)
11.9.1 Sanpower (Dendreon) Corporation Information
11.9.2 Sanpower (Dendreon) Description and Business Overview
11.9.3 Sanpower (Dendreon) Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Sanpower (Dendreon) Dendritic Cell Cancer Vaccine Products Offered
11.9.5 Sanpower (Dendreon) Related Developments
11.10 Elios Therapeutics
11.10.1 Elios Therapeutics Corporation Information
11.10.2 Elios Therapeutics Description and Business Overview
11.10.3 Elios Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Elios Therapeutics Dendritic Cell Cancer Vaccine Products Offered
11.10.5 Elios Therapeutics Related Developments
11.1 Medigene
11.1.1 Medigene Corporation Information
11.1.2 Medigene Description and Business Overview
11.1.3 Medigene Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Medigene Dendritic Cell Cancer Vaccine Products Offered
11.1.5 Medigene Related Developments
11.12 Kiromic
11.12.1 Kiromic Corporation Information
11.12.2 Kiromic Description and Business Overview
11.12.3 Kiromic Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Kiromic Products Offered
11.12.5 Kiromic Related Developments
11.13 Merck
11.13.1 Merck Corporation Information
11.13.2 Merck Description and Business Overview
11.13.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Merck Products Offered
11.13.5 Merck Related Developments
11.14 Northwest Biotherapeutics
11.14.1 Northwest Biotherapeutics Corporation Information
11.14.2 Northwest Biotherapeutics Description and Business Overview
11.14.3 Northwest Biotherapeutics Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Northwest Biotherapeutics Products Offered
11.14.5 Northwest Biotherapeutics Related Developments
11.15 Glaxo Smith Kline
11.15.1 Glaxo Smith Kline Corporation Information
11.15.2 Glaxo Smith Kline Description and Business Overview
11.15.3 Glaxo Smith Kline Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Glaxo Smith Kline Products Offered
11.15.5 Glaxo Smith Kline Related Developments
11.16 ImmunoCellular
11.16.1 ImmunoCellular Corporation Information
11.16.2 ImmunoCellular Description and Business Overview
11.16.3 ImmunoCellular Sales, Revenue and Gross Margin (2015-2020)
11.16.4 ImmunoCellular Products Offered
11.16.5 ImmunoCellular Related Developments
11.17 Tella
11.17.1 Tella Corporation Information
11.17.2 Tella Description and Business Overview
11.17.3 Tella Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Tella Products Offered
11.17.5 Tella Related Developments
11.18 Vaxil Bio
11.18.1 Vaxil Bio Corporation Information
11.18.2 Vaxil Bio Description and Business Overview
11.18.3 Vaxil Bio Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Vaxil Bio Products Offered
11.18.5 Vaxil Bio Related Developments
11.19 Medigene
11.19.1 Medigene Corporation Information
11.19.2 Medigene Description and Business Overview
11.19.3 Medigene Sales, Revenue and Gross Margin (2015-2020)
11.19.4 Medigene Products Offered
11.19.5 Medigene Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Dendritic Cell Cancer Vaccine Market Estimates and Projections by Region
12.1.1 Global Dendritic Cell Cancer Vaccine Sales Forecast by Regions 2021-2026
12.1.2 Global Dendritic Cell Cancer Vaccine Revenue Forecast by Regions 2021-2026
12.2 North America Dendritic Cell Cancer Vaccine Market Size Forecast (2021-2026)
12.2.1 North America: Dendritic Cell Cancer Vaccine Sales Forecast (2021-2026)
12.2.2 North America: Dendritic Cell Cancer Vaccine Revenue Forecast (2021-2026)
12.2.3 North America: Dendritic Cell Cancer Vaccine Market Size Forecast by Country (2021-2026)
12.3 Europe Dendritic Cell Cancer Vaccine Market Size Forecast (2021-2026)
12.3.1 Europe: Dendritic Cell Cancer Vaccine Sales Forecast (2021-2026)
12.3.2 Europe: Dendritic Cell Cancer Vaccine Revenue Forecast (2021-2026)
12.3.3 Europe: Dendritic Cell Cancer Vaccine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Dendritic Cell Cancer Vaccine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Dendritic Cell Cancer Vaccine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Dendritic Cell Cancer Vaccine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Dendritic Cell Cancer Vaccine Market Size Forecast by Region (2021-2026)
12.5 Latin America Dendritic Cell Cancer Vaccine Market Size Forecast (2021-2026)
12.5.1 Latin America: Dendritic Cell Cancer Vaccine Sales Forecast (2021-2026)
12.5.2 Latin America: Dendritic Cell Cancer Vaccine Revenue Forecast (2021-2026)
12.5.3 Latin America: Dendritic Cell Cancer Vaccine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Dendritic Cell Cancer Vaccine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Dendritic Cell Cancer Vaccine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Dendritic Cell Cancer Vaccine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Dendritic Cell Cancer Vaccine Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Dendritic Cell Cancer Vaccine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Dendritic Cell Cancer Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Dendritic Cell Cancer Vaccine Market Segments
Table 2. Ranking of Global Top Dendritic Cell Cancer Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Dendritic Cell Cancer Vaccine Market Size Growth Rate by Type 2020-2026 (K Doses) & (US$ Million)
Table 4. Major Manufacturers of CreaVax
Table 5. Major Manufacturers of Sipuleucel-T (Provenge)
Table 6. Major Manufacturers of Others
Table 7. Global Dendritic Cell Cancer Vaccine Market Size Growth Rate by Application 2020-2026 (K Doses)
Table 8. Global Dendritic Cell Cancer Vaccine Market Size by Region (K Doses) & (US$ Million): 2020 VS 2026
Table 9. Global Dendritic Cell Cancer Vaccine Sales by Regions 2015-2020 (K Doses)
Table 10. Global Dendritic Cell Cancer Vaccine Sales Market Share by Regions (2015-2020)
Table 11. Global Dendritic Cell Cancer Vaccine Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Dendritic Cell Cancer Vaccine Sales by Manufacturers (2015-2020) (K Doses)
Table 13. Global Dendritic Cell Cancer Vaccine Sales Share by Manufacturers (2015-2020)
Table 14. Global Dendritic Cell Cancer Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Dendritic Cell Cancer Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dendritic Cell Cancer Vaccine as of 2019)
Table 16. Dendritic Cell Cancer Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Dendritic Cell Cancer Vaccine Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Dendritic Cell Cancer Vaccine Price (2015-2020) (USD/Dose)
Table 19. Dendritic Cell Cancer Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Dendritic Cell Cancer Vaccine Product Type
Table 21. Date of International Manufacturers Enter into Dendritic Cell Cancer Vaccine Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Dendritic Cell Cancer Vaccine Sales by Type (2015-2020) (K Doses)
Table 24. Global Dendritic Cell Cancer Vaccine Sales Share by Type (2015-2020)
Table 25. Global Dendritic Cell Cancer Vaccine Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Dendritic Cell Cancer Vaccine Revenue Share by Type (2015-2020)
Table 27. Dendritic Cell Cancer Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/Dose)
Table 28. Global Dendritic Cell Cancer Vaccine Sales by Application (2015-2020) (K Doses)
Table 29. Global Dendritic Cell Cancer Vaccine Sales Share by Application (2015-2020)
Table 30. North America Dendritic Cell Cancer Vaccine Sales by Country (2015-2020) (K Doses)
Table 31. North America Dendritic Cell Cancer Vaccine Sales Market Share by Country (2015-2020)
Table 32. North America Dendritic Cell Cancer Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Dendritic Cell Cancer Vaccine Revenue Market Share by Country (2015-2020)
Table 34. North America Dendritic Cell Cancer Vaccine Sales by Type (2015-2020) (K Doses)
Table 35. North America Dendritic Cell Cancer Vaccine Sales Market Share by Type (2015-2020)
Table 36. North America Dendritic Cell Cancer Vaccine Sales by Application (2015-2020) (K Doses)
Table 37. North America Dendritic Cell Cancer Vaccine Sales Market Share by Application (2015-2020)
Table 38. Europe Dendritic Cell Cancer Vaccine Sales by Country (2015-2020) (K Doses)
Table 39. Europe Dendritic Cell Cancer Vaccine Sales Market Share by Country (2015-2020)
Table 40. Europe Dendritic Cell Cancer Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Dendritic Cell Cancer Vaccine Revenue Market Share by Country (2015-2020)
Table 42. Europe Dendritic Cell Cancer Vaccine Sales by Type (2015-2020) (K Doses)
Table 43. Europe Dendritic Cell Cancer Vaccine Sales Market Share by Type (2015-2020)
Table 44. Europe Dendritic Cell Cancer Vaccine Sales by Application (2015-2020) (K Doses)
Table 45. Europe Dendritic Cell Cancer Vaccine Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Dendritic Cell Cancer Vaccine Sales by Region (2015-2020) (K Doses)
Table 47. Asia Pacific Dendritic Cell Cancer Vaccine Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Dendritic Cell Cancer Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Dendritic Cell Cancer Vaccine Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Dendritic Cell Cancer Vaccine Sales by Type (2015-2020) (K Doses)
Table 51. Asia Pacific Dendritic Cell Cancer Vaccine Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Dendritic Cell Cancer Vaccine Sales by Application (2015-2020) (K Doses)
Table 53. Asia Pacific Dendritic Cell Cancer Vaccine Sales Market Share by Application (2015-2020)
Table 54. Latin America Dendritic Cell Cancer Vaccine Sales by Country (2015-2020) (K Doses)
Table 55. Latin America Dendritic Cell Cancer Vaccine Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Dendritic Cell Cancer Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Dendritic Cell Cancer Vaccine Revenue Market Share by Country (2015-2020)
Table 58. Latin America Dendritic Cell Cancer Vaccine Sales by Type (2015-2020) (K Doses)
Table 59. Latin America Dendritic Cell Cancer Vaccine Sales Market Share by Type (2015-2020)
Table 60. Latin America Dendritic Cell Cancer Vaccine Sales by Application (2015-2020) (K Doses)
Table 61. Latin America Dendritic Cell Cancer Vaccine Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Dendritic Cell Cancer Vaccine Sales by Country (2015-2020) (K Doses)
Table 63. Middle East and Africa Dendritic Cell Cancer Vaccine Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Dendritic Cell Cancer Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Dendritic Cell Cancer Vaccine Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Dendritic Cell Cancer Vaccine Sales by Type (2015-2020) (K Doses)
Table 67. Middle East and Africa Dendritic Cell Cancer Vaccine Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Dendritic Cell Cancer Vaccine Sales by Application (2015-2020) (K Doses)
Table 69. Middle East and Africa Dendritic Cell Cancer Vaccine Sales Market Share by Application (2015-2020)
Table 70. Medigene Corporation Information
Table 71. Medigene Description and Major Businesses
Table 72. Medigene Dendritic Cell Cancer Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 73. Medigene Product
Table 74. Medigene Recent Development
Table 75. Activarti Corporation Information
Table 76. Activarti Description and Major Businesses
Table 77. Activarti Dendritic Cell Cancer Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 78. Activarti Product
Table 79. Activarti Recent Development
Table 80. Argos Therapeutics Corporation Information
Table 81. Argos Therapeutics Description and Major Businesses
Table 82. Argos Therapeutics Dendritic Cell Cancer Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 83. Argos Therapeutics Product
Table 84. Argos Therapeutics Recent Development
Table 85. Batavia Bioservices Corporation Information
Table 86. Batavia Bioservices Description and Major Businesses
Table 87. Batavia Bioservices Dendritic Cell Cancer Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 88. Batavia Bioservices Product
Table 89. Batavia Bioservices Recent Development
Table 90. Bellicum Pharmaceuticals Corporation Information
Table 91. Bellicum Pharmaceuticals Description and Major Businesses
Table 92. Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 93. Bellicum Pharmaceuticals Product
Table 94. Bellicum Pharmaceuticals Recent Development
Table 95. Creagene Corporation Information
Table 96. Creagene Description and Major Businesses
Table 97. Creagene Dendritic Cell Cancer Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 98. Creagene Product
Table 99. Creagene Recent Development
Table 100. DanDrit Biotech Corporation Information
Table 101. DanDrit Biotech Description and Major Businesses
Table 102. DanDrit Biotech Dendritic Cell Cancer Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 103. DanDrit Biotech Product
Table 104. DanDrit Biotech Recent Development
Table 105. DCPrime Corporation Information
Table 106. DCPrime Description and Major Businesses
Table 107. DCPrime Dendritic Cell Cancer Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 108. DCPrime Product
Table 109. DCPrime Recent Development
Table 110. Sanpower (Dendreon) Corporation Information
Table 111. Sanpower (Dendreon) Description and Major Businesses
Table 112. Sanpower (Dendreon) Dendritic Cell Cancer Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 113. Sanpower (Dendreon) Product
Table 114. Sanpower (Dendreon) Recent Development
Table 115. Elios Therapeutics Corporation Information
Table 116. Elios Therapeutics Description and Major Businesses
Table 117. Elios Therapeutics Dendritic Cell Cancer Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 118. Elios Therapeutics Product
Table 119. Elios Therapeutics Recent Development
Table 120. Immunicum Corporation Information
Table 121. Immunicum Description and Major Businesses
Table 122. Immunicum Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 123. Immunicum Product
Table 124. Immunicum Recent Development
Table 125. Kiromic Corporation Information
Table 126. Kiromic Description and Major Businesses
Table 127. Kiromic Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 128. Kiromic Product
Table 129. Kiromic Recent Development
Table 130. Merck Corporation Information
Table 131. Merck Description and Major Businesses
Table 132. Merck Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 133. Merck Product
Table 134. Merck Recent Development
Table 135. Northwest Biotherapeutics Corporation Information
Table 136. Northwest Biotherapeutics Description and Major Businesses
Table 137. Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 138. Northwest Biotherapeutics Product
Table 139. Northwest Biotherapeutics Recent Development
Table 140. Glaxo Smith Kline Corporation Information
Table 141. Glaxo Smith Kline Description and Major Businesses
Table 142. Glaxo Smith Kline Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 143. Glaxo Smith Kline Product
Table 144. Glaxo Smith Kline Recent Development
Table 145. ImmunoCellular Corporation Information
Table 146. ImmunoCellular Description and Major Businesses
Table 147. ImmunoCellular Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 148. ImmunoCellular Product
Table 149. ImmunoCellular Recent Development
Table 150. Tella Corporation Information
Table 151. Tella Description and Major Businesses
Table 152. Tella Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 153. Tella Product
Table 154. Tella Recent Development
Table 155. Vaxil Bio Corporation Information
Table 156. Vaxil Bio Description and Major Businesses
Table 157. Vaxil Bio Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 158. Vaxil Bio Product
Table 159. Vaxil Bio Recent Development
Table 160. Medigene Corporation Information
Table 161. Medigene Description and Major Businesses
Table 162. Medigene Dendritic Cell Cancer Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 163. Medigene Product
Table 164. Medigene Recent Development
Table 165. Global Dendritic Cell Cancer Vaccine Sales Forecast by Regions (2021-2026) (K Doses)
Table 166. Global Dendritic Cell Cancer Vaccine Sales Market Share Forecast by Regions (2021-2026)
Table 167. Global Dendritic Cell Cancer Vaccine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 168. Global Dendritic Cell Cancer Vaccine Revenue Market Share Forecast by Regions (2021-2026)
Table 169. North America: Dendritic Cell Cancer Vaccine Sales Forecast by Country (2021-2026) (K Doses)
Table 170. North America: Dendritic Cell Cancer Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 171. Europe: Dendritic Cell Cancer Vaccine Sales Forecast by Country (2021-2026) (K Doses)
Table 172. Europe: Dendritic Cell Cancer Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 173. Asia Pacific: Dendritic Cell Cancer Vaccine Sales Forecast by Region (2021-2026) (K Doses)
Table 174. Asia Pacific: Dendritic Cell Cancer Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 175. Latin America: Dendritic Cell Cancer Vaccine Sales Forecast by Country (2021-2026) (K Doses)
Table 176. Latin America: Dendritic Cell Cancer Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 177. Middle East and Africa: Dendritic Cell Cancer Vaccine Sales Forecast by Country (2021-2026) (K Doses)
Table 178. Middle East and Africa: Dendritic Cell Cancer Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 179. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 180. Key Challenges
Table 181. Market Risks
Table 182. Main Points Interviewed from Key Dendritic Cell Cancer Vaccine Players
Table 183. Dendritic Cell Cancer Vaccine Customers List
Table 184. Dendritic Cell Cancer Vaccine Distributors List
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
List of Figures
Figure 1. Dendritic Cell Cancer Vaccine Product Picture
Figure 2. Global Dendritic Cell Cancer Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. CreaVax Product Picture
Figure 4. Sipuleucel-T (Provenge) Product Picture
Figure 5. Others Product Picture
Figure 6. Global Dendritic Cell Cancer Vaccine Sales Market Share by Application in 2020 & 2026
Figure 7. Pediatrics
Figure 8. Adults
Figure 9. Dendritic Cell Cancer Vaccine Report Years Considered
Figure 10. Global Dendritic Cell Cancer Vaccine Market Size 2015-2026 (US$ Million)
Figure 11. Global Dendritic Cell Cancer Vaccine Sales 2015-2026 (K Doses)
Figure 12. Global Dendritic Cell Cancer Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Dendritic Cell Cancer Vaccine Sales Market Share by Region (2015-2020)
Figure 14. Global Dendritic Cell Cancer Vaccine Sales Market Share by Region in 2019
Figure 15. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Region (2015-2020)
Figure 16. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Region in 2019
Figure 17. Global Dendritic Cell Cancer Vaccine Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Dendritic Cell Cancer Vaccine Revenue in 2019
Figure 19. Dendritic Cell Cancer Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Dendritic Cell Cancer Vaccine Sales Market Share by Type (2015-2020)
Figure 21. Global Dendritic Cell Cancer Vaccine Sales Market Share by Type in 2019
Figure 22. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Type (2015-2020)
Figure 23. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Type in 2019
Figure 24. Global Dendritic Cell Cancer Vaccine Market Share by Price Range (2015-2020)
Figure 25. Global Dendritic Cell Cancer Vaccine Sales Market Share by Application (2015-2020)
Figure 26. Global Dendritic Cell Cancer Vaccine Sales Market Share by Application in 2019
Figure 27. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Application (2015-2020)
Figure 28. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Application in 2019
Figure 29. North America Dendritic Cell Cancer Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 30. North America Dendritic Cell Cancer Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Dendritic Cell Cancer Vaccine Sales Market Share by Country in 2019
Figure 32. North America Dendritic Cell Cancer Vaccine Revenue Market Share by Country in 2019
Figure 33. U.S. Dendritic Cell Cancer Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 34. U.S. Dendritic Cell Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Dendritic Cell Cancer Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 36. Canada Dendritic Cell Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Dendritic Cell Cancer Vaccine Market Share by Type in 2019
Figure 38. North America Dendritic Cell Cancer Vaccine Market Share by Application in 2019
Figure 39. Europe Dendritic Cell Cancer Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 40. Europe Dendritic Cell Cancer Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Dendritic Cell Cancer Vaccine Sales Market Share by Country in 2019
Figure 42. Europe Dendritic Cell Cancer Vaccine Revenue Market Share by Country in 2019
Figure 43. Germany Dendritic Cell Cancer Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 44. Germany Dendritic Cell Cancer Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Dendritic Cell Cancer Vaccine Sales Growth Rate (2015-2020) (K Doses)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global BCG Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global BCG Vaccine market size was valued at US$ 365.6 million in 2023. With growing demand in downstream market, the BCG Vaccine is forecast to a readjusted size of US$ 542.8 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global BCG Vaccine market. BCG Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing cost......

Global Peptide Cancer Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115

According to our LPI (LP Information) latest study, the global Peptide Cancer Vaccine market size was valued at US$ 535 million in 2023. With growing demand in downstream market, the Peptide Cancer Vaccine is forecast to a readjusted size of US$ 1978.2 million by 2030 with a CAGR of 20.5% during review period. The research report highlights the growth potential of the global Peptide Cancer Vaccine market. Peptide Cancer Vaccine are expected to show stable growth in the future market. How......

Global Cancer Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 101

Market Overview of Global Cancer Vaccine market: According to our latest research, the global Cancer Vaccine market looks promising in the next 5 years. As of 2022, the global Cancer Vaccine market was estimated at USD 7198.2 million, and it's anticipated to reach USD 33936.62 million in 2028, with a CAGR of 29.49% during the forecast years. A cancer vaccine is a type of immunotherapy that boost the body's natural defenses by stimulating the immune system to recognize and cur......

Global Lung Cancer Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 12-Dec-2023        Price: US 3380 Onwards        Pages: 102

Market Overview of Global Lung Cancer Vaccines market: According to our latest research, the global Lung Cancer Vaccines market looks promising in the next 5 years. As of 2022, the global Lung Cancer Vaccines market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Lung Cancer Vaccines,A cancer vaccine for lung cance This report covers a research time span from 2018 to 2028, and ......

Global Cancer Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 105

Market Overview of Global Cancer Vaccines market: According to our latest research, the global Cancer Vaccines market looks promising in the next 5 years. As of 2022, the global Cancer Vaccines market was estimated at USD 5773.14 million, and it's anticipated to reach USD 15406.41 million in 2028, with a CAGR of 17.77% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cancer Vacci......

Global Dendritic Cell Cancer Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 110

Market Overview of Global Dendritic Cell Cancer Vaccine market: According to our latest research, the global Dendritic Cell Cancer Vaccine market looks promising in the next 5 years. As of 2022, the global Dendritic Cell Cancer Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Dendritic cells (DC) are one of the major antigen presenting cells found in lymphoid organs. The main fu......

Global BCG Vaccine Market Research Report 2023, Forecast to 2028

Published: 14-Nov-2023        Price: US 2680 Onwards        Pages: 135

BCG Vaccine is not given as part of the routine NHS vaccination schedule. It's given on the NHS only when a child or adult is thought to have an increased risk of coming into contact with TB. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage o......

Global BCG Vaccine Professional Survey Report 2023, Forecast to 2028

Published: 14-Nov-2023        Price: US 3280 Onwards        Pages: 105

BCG Vaccine is not given as part of the routine NHS vaccination schedule. It's given on the NHS only when a child or adult is thought to have an increased risk of coming into contact with TB. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage o......

Infectious Vaccine Collaboration and Licensing Deals 2016-2023

Published: 01-Nov-2023        Price: US 3995 Onwards        Pages: 300

Infectious Vaccine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the infectious vaccine deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of infectious vaccine deals from 2016 to 2023. The report provides a detailed understanding and analysis of how and why companies enter infectious vaccine deals. These deals tend to be multicomponent, starting with......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs